ilomastat has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Giricz, Z; Görbe, A; Kocsis, GF; Kupai, K; Murlasits, Z; Pipis, J; Puskás, LG; Varga-Orvos, Z | 1 |
| Bell, RM; Bruce-Hickman, D; Davidson, S; Hendry, C; Kunuthur, SP; Yellon, DM | 1 |
2 other study(ies) available for ilomastat and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Topics: Animals; Disease Models, Animal; Enzyme Activation; Hydroxamic Acids; Indoles; Ischemic Preconditioning, Myocardial; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Protease Inhibitors; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase; Superoxides; Time Factors; Up-Regulation | 2010 |
Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.
Topics: Animals; Blotting, Western; Cyclophilins; Extracellular Signal-Regulated MAP Kinases; Hydroxamic Acids; Indoles; Male; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Peptidyl-Prolyl Isomerase F; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2013 |